钙网蛋白单倍剂量不足增强干细胞活性且为小鼠骨髓增殖性肿瘤发生所必需
该研究通过构建造血细胞特异性Calr缺陷小鼠,发现CALR缺陷对血常规影响不大,但出现红系生成减少、髓系祖细胞增多及脾脏髓外造血等MPN特征。移植实验显示Calr单倍剂量不足促进HSC自我更新,且仅同时携带CALR突变和Calr单倍剂量不足的Lineage-Sca1+c-kit+细胞在竞争条件下可致MPN,表明CALR单倍剂量不足是CALR突变型MPN发生的必要条件。
要点
- CALR缺陷小鼠出现红系生成减少、髓系祖细胞增多及脾脏髓外造血等MPN特征。
- Calr单倍剂量不足促进HSC自我更新,并恢复CALR突变损伤的HSC自我更新能力。
- 仅CALR突变合并Calr单倍剂量不足的LSK细胞在竞争条件下可致MPN。
核心结论
- Calr单倍剂量不足增强HSC自我更新,并且是CALR突变型MPN发生的必要条件。
研究设计与样本
- 构建造血细胞特异性Calr缺陷小鼠,并进行移植实验。
- 构建Calr单倍剂量不足的CALRdel52突变转基因小鼠以模拟人类MPN患者。
主要发现
- CALR缺陷对小鼠外周血白细胞计数、血红蛋白水平或血小板计数影响不大。
- Calr缺陷小鼠骨髓红系生成减少、髓系祖细胞增多,脾脏出现髓外造血。
- 移植实验显示Calr单倍剂量不足促进HSC自我更新。
- Calr单倍剂量不足恢复CALR突变损伤的HSC自我更新能力。
- 仅同时携带CALR突变和Calr单倍剂量不足的Lineage-Sca1+c-kit+细胞在竞争条件下移植后使受体小鼠发生MPN。
临床怎么用
- 提示CALR单倍剂量不足状态应纳入CALR突变型MPN发生机制与风险评估的考量。
局限性
- 研究基于小鼠模型,结论向人类MPN临床转化的适用性尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mutations in JAK2, myeloproliferative leukemia virus (MPL), or calreticulin (CALR) occur in hematopoietic stem cells (HSCs) and are detected in more than 80% of patients with myeloproliferative neoplasms (MPNs). They are thought to play a driver role in MPN pathogenesis via autosomal activation of the JAK-STAT signaling cascade. Mutant CALR binds to MPL, activates downstream MPL signaling cascades, and induces essential thrombocythemia in mice. However, embryonic lethality of Calr-deficient mice precludes determination of a role for CALR in hematopoiesis. To clarify the role of CALR in normal hematopoiesis and MPN pathogenesis, we generated hematopoietic cell-specific Calr-deficient mice. CALR deficiency had little effect on the leukocyte count, hemoglobin levels, or platelet count in peripheral blood. However, Calr-deficient mice showed some hematopoietic properties of MPN, including decreased erythropoiesis and increased myeloid progenitor cells in the bone marrow and extramedullary hematopoiesis in the spleen. Transplantation experiments revealed that Calr haploinsufficiency promoted the self-renewal capacity of HSCs. We generated CALRdel52 mutant transgenic mice with Calr haploinsufficiency as a model that mimics human MPN patients and found that Calr haploinsufficiency restored the self-renewal capacity of HSCs damaged by CALR mutations. Only recipient mice transplanted with Lineage-Sca1+c-kit+ cells harboring both CALR mutation and Calr haploinsufficiency developed MPN in competitive conditions, showing that CALR haploinsufficiency was necessary for the onset of CALR-mutated MPNs.
引用
- Shide K, Kameda T, Kamiunten A, et al. Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice. Blood. 2020. PMID: 32219445. doi:10.1182/blood.2019003358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。